drugset / Trial / NCT05934409
Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery
Recruiting
40 enrolled
University of Sherbrooke
Centre de recherche du Centre hospitalier universitaire de Sherbrooke · collabInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The present protocol aims to understand and establish whether there is a causal link between adipose tissue metabolic remodeling and Type 2 Diabetes (T2D) remission after bariatric surgery. All participants will have a bariatric surgery, divided in 2 groups: with or without T2D.
Timeline
- Start
- 2023-11-01
- Primary completion
- 2028-01-31
- Completion
- 2028-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niacin | Small molecule | 150 mg | — |